Non-cystic Fibrosis Bronchiectasis: Is early diagnosis missed?
Abstract
No abstract
References
1. Neves P C, Guerra M, Ponce P, Miranda J, Vouga L. Noncystic fibrosis bronchiectasis Interact Cardio Vasc Thorac Surg. 2012; 13: 619-625.
2. Singh N. Bronchiectasis: Pulmonary and Critical Care Bulletin Vol. XIII, No. 1, Jan. 2007: http://www.indiachest. org/pdf_files/Jan%2007.pdf
3. Barker A F. and Bardana E J, Jr.”Bronchiectasis: Update of an Orphan Disease”, American Review of Respiratory Disease 1988; 137: 969-978.
4. Karakoc GB1, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatr Pulmonol. 2001; 32:175-8.
5. Mobaireek KF. Noncystic fibrosis bronchiectasis: Is it an orphan disease? Ann Thorac Med. 2007; 2: 2.
6. Eastham K, Fall A, Mitchell L, Spencer D. The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax. 2004;59: 324-327.
7. Lazarus A, Myers J, Fuhrer G.Bronchiectasis in adults: a review. Postgrad Med. 2008;120:113-21
8. Gupta S, Handa K, Kasliwa R, Bajpai P. A case of Kartagener’s syndrome: Importance of early diagnosis and treatment. Indian J Hum Genet. 2013;192: 266-269.
9. Patil M, Maske M, Joshi JM. Bronchiectasis in Turner Syndrome. Lung India.2006;23:121-122
10. Tyagi R, Sahu S. Kartagener Syndrome : A Case report. The Indian Practitioner. 2015;68(4):38-39
11. Air Quality Data (US EPA Air Quality Index) http://mumbai. usconsulate.gov/airqualitydata.html
12. Gupta RK, Chandra A, Gautam PB. Allergic Bronchopulmonary Aspergillosis – A Clinical Review. JAPI 2012; 60: 46-51
13. Gordon SB, Bruce NG, Grigg J, Hibberd PL, Kurmi OP, Lam KB et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med.2014; 2:823-60.
14. Balakrishnan K, RamaswamyP, Sambandam S et al. Air pollution from household solid fuel combustion in India: an overview of exposure and health relatedinformation to inform health research priorities.Glob Health Action. 2011; 4: 10.3402/gha.v4i0.5638.
15. Gao Y, Guan W, Xu G, Lin Z, Tang Y, Lin Z et al.The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: A prospective study. Chest. 2014 Nov 20.doi: 10.1378/chest.14-1961. [Epub ahead of print]
16. Gao, Y, Guan WJ, Xu G, Tang Y, Gao Y, Lin ZY. Macrolide Therapy in Adults and Children with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and Meta-Analysis PLoS One. 2014; 9: e90047.
17. Nicolini A, Cardini F, Landucci N, Lanata S, Ferrari-Bravo M, Barlascini C. Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis BMC Pulm Med. 2013; 13: 21.
18. Chalmers JD1, Loebinger M, Aliberti S. Challenges in the development of new therapies for bronchiectasis. Expert Opin Pharmacother. 2015 ;16:833-50.
19. Sidhu MK, Mandal P, Hill AT. Developing drug therapies in bronchiectasis. Expert Opin Investig Drugs. 2015;24:169-81.
2. Singh N. Bronchiectasis: Pulmonary and Critical Care Bulletin Vol. XIII, No. 1, Jan. 2007: http://www.indiachest. org/pdf_files/Jan%2007.pdf
3. Barker A F. and Bardana E J, Jr.”Bronchiectasis: Update of an Orphan Disease”, American Review of Respiratory Disease 1988; 137: 969-978.
4. Karakoc GB1, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatr Pulmonol. 2001; 32:175-8.
5. Mobaireek KF. Noncystic fibrosis bronchiectasis: Is it an orphan disease? Ann Thorac Med. 2007; 2: 2.
6. Eastham K, Fall A, Mitchell L, Spencer D. The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax. 2004;59: 324-327.
7. Lazarus A, Myers J, Fuhrer G.Bronchiectasis in adults: a review. Postgrad Med. 2008;120:113-21
8. Gupta S, Handa K, Kasliwa R, Bajpai P. A case of Kartagener’s syndrome: Importance of early diagnosis and treatment. Indian J Hum Genet. 2013;192: 266-269.
9. Patil M, Maske M, Joshi JM. Bronchiectasis in Turner Syndrome. Lung India.2006;23:121-122
10. Tyagi R, Sahu S. Kartagener Syndrome : A Case report. The Indian Practitioner. 2015;68(4):38-39
11. Air Quality Data (US EPA Air Quality Index) http://mumbai. usconsulate.gov/airqualitydata.html
12. Gupta RK, Chandra A, Gautam PB. Allergic Bronchopulmonary Aspergillosis – A Clinical Review. JAPI 2012; 60: 46-51
13. Gordon SB, Bruce NG, Grigg J, Hibberd PL, Kurmi OP, Lam KB et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med.2014; 2:823-60.
14. Balakrishnan K, RamaswamyP, Sambandam S et al. Air pollution from household solid fuel combustion in India: an overview of exposure and health relatedinformation to inform health research priorities.Glob Health Action. 2011; 4: 10.3402/gha.v4i0.5638.
15. Gao Y, Guan W, Xu G, Lin Z, Tang Y, Lin Z et al.The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: A prospective study. Chest. 2014 Nov 20.doi: 10.1378/chest.14-1961. [Epub ahead of print]
16. Gao, Y, Guan WJ, Xu G, Tang Y, Gao Y, Lin ZY. Macrolide Therapy in Adults and Children with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and Meta-Analysis PLoS One. 2014; 9: e90047.
17. Nicolini A, Cardini F, Landucci N, Lanata S, Ferrari-Bravo M, Barlascini C. Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis BMC Pulm Med. 2013; 13: 21.
18. Chalmers JD1, Loebinger M, Aliberti S. Challenges in the development of new therapies for bronchiectasis. Expert Opin Pharmacother. 2015 ;16:833-50.
19. Sidhu MK, Mandal P, Hill AT. Developing drug therapies in bronchiectasis. Expert Opin Investig Drugs. 2015;24:169-81.
Published
2019-08-19
How to Cite
Rama Vaidya, Kinjal Modi. (2019). Non-cystic Fibrosis Bronchiectasis: Is early diagnosis missed?. The Indian Practitioner, 68(4), 6-7. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/628
Section
Editorial
